Lam Research (NASDAQ:LRCX) Shares Unloaded Sen. John Boozman

Senator John Boozman (R-Arkansas) recently sold shares of Lam Research Co. NASDAQ: LRCX. In a filing disclosed on May 14th, the Senator disclosed that they had sold between $1,001 and $15,000 in Lam Research stock on April 16th.

Senator John Boozman also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Salesforce NYSE: CRM on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/22/2025.
• Purchased $1,001 - $15,000 in shares of Microsoft NASDAQ: MSFT on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of Oracle NYSE: ORCL on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Gilead Sciences NASDAQ: GILD on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/15/2025.
• Sold $1,001 - $15,000 in shares of Bank of America NYSE: BAC on 4/15/2025.
• Purchased $1,001 - $15,000 in shares of iShares iBoxx $ High Yield Corporate Bond ETF NYSEARCA: HYG on 4/9/2025.

Lam Research Stock Down 0.3%

LRCX opened at $84.97 on Thursday. The company has a debt-to-equity ratio of 0.51, a current ratio of 2.54 and a quick ratio of 1.73. The stock has a market capitalization of $108.69 billion, a price-to-earnings ratio of 25.81, a price-to-earnings-growth ratio of 1.47 and a beta of 1.64. The business has a 50-day moving average of $71.91 and a two-hundred day moving average of $75.36. Lam Research Co. has a 12 month low of $56.32 and a 12 month high of $113.00.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The semiconductor company reported $1.04 EPS for the quarter, beating the consensus estimate of $1.00 by $0.04. The company had revenue of $4.72 billion during the quarter, compared to analysts' expectations of $4.64 billion. Lam Research had a return on equity of 51.86% and a net margin of 26.49%. The firm's revenue was up 24.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $7.79 EPS. On average, research analysts expect that Lam Research Co. will post 3.71 earnings per share for the current year.

Insider Activity

In related news, SVP Seshasayee Varadarajan sold 110,080 shares of the company's stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $90.00, for a total transaction of $9,907,200.00. Following the sale, the senior vice president now directly owns 179,084 shares of the company's stock, valued at approximately $16,117,560. This represents a 38.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.29% of the company's stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. Evercore ISI boosted their target price on Lam Research from $95.00 to $99.00 and gave the stock an "outperform" rating in a report on Thursday, April 24th. Morgan Stanley boosted their target price on Lam Research from $81.00 to $82.00 and gave the stock an "equal weight" rating in a report on Thursday, April 24th. Sanford C. Bernstein upgraded Lam Research from a "market perform" rating to an "outperform" rating and boosted their target price for the stock from $85.00 to $91.00 in a report on Thursday, January 30th. Deutsche Bank Aktiengesellschaft set a $70.00 target price on Lam Research and gave the stock a "hold" rating in a report on Thursday, April 24th. Finally, TD Securities decreased their target price on Lam Research from $110.00 to $100.00 and set a "buy" rating for the company in a report on Thursday, April 24th. Seven equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $91.56.

Hedge Funds Weigh In On Lam Research

Several institutional investors and hedge funds have recently made changes to their positions in the business. Meridian Wealth Management LLC boosted its stake in shares of Lam Research by 1.4% during the 1st quarter. Meridian Wealth Management LLC now owns 9,732 shares of the semiconductor company's stock valued at $707,000 after buying an additional 130 shares during the last quarter. GW&K Investment Management LLC boosted its stake in shares of Lam Research by 10.1% during the 1st quarter. GW&K Investment Management LLC now owns 1,534 shares of the semiconductor company's stock valued at $112,000 after buying an additional 141 shares during the last quarter. Dorsey & Whitney Trust CO LLC boosted its stake in shares of Lam Research by 1.2% during the 1st quarter. Dorsey & Whitney Trust CO LLC now owns 12,498 shares of the semiconductor company's stock valued at $909,000 after buying an additional 146 shares during the last quarter. Citizens National Bank Trust Department boosted its stake in shares of Lam Research by 34.0% during the 1st quarter. Citizens National Bank Trust Department now owns 603 shares of the semiconductor company's stock valued at $44,000 after buying an additional 153 shares during the last quarter. Finally, Progressive Investment Management Corp boosted its stake in shares of Lam Research by 0.4% during the 1st quarter. Progressive Investment Management Corp now owns 42,581 shares of the semiconductor company's stock valued at $3,096,000 after buying an additional 156 shares during the last quarter. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

About Senator Boozman

John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas' U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman's academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.